###begin article-title 0
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 29 32 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Human Leukocyte Antigens and HIV Type 1 Viral Load in Early and Chronic Infection: Predominance of Evolving Relationships
###end article-title 0
###begin p 1
Conceived and designed the experiments: JT JM SA EH RK. Performed the experiments: WS LH. Analyzed the data: JT RM WS IB LH PKF. Contributed reagents/materials/analysis tools: JT RM IB PKF JM SA EH RK. Wrote the paper: JT SA EH RK.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 26 31 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 207 212 <span type="species:ncbi:9606">human</span>
###xml 241 246 <span type="species:ncbi:9606">human</span>
During untreated, chronic HIV-1 infection, plasma viral load (VL) is a relatively stable quantitative trait that has clinical and epidemiological implications. Immunogenetic research has established various human genetic factors, especially human leukocyte antigen (HLA) variants, as independent determinants of VL set-point.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 529 530 529 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 634 639 634 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A</italic>
###xml 644 649 644 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C</italic>
###xml 830 832 826 828 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 841 842 837 838 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 948 949 944 945 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 107 112 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
To identify and clarify HLA alleles that are associated with either transient or durable immune control of HIV-1 infection, we evaluated the relationships of HLA class I and class II alleles with VL among 563 seroprevalent Zambians (SPs) who were seropositive at enrollment and 221 seroconverters (SCs) who became seropositive during quarterly follow-up visits. After statistical adjustments for non-genetic factors (sex and age), two unfavorable alleles (A*3601 and DRB1*0102) were independently associated with high VL in SPs (p<0.01) but not in SCs. In contrast, favorable HLA variants, mainly A*74, B*13, B*57 (or Cw*18), and one HLA-A and HLA-C combination (A*30+Cw*03), dominated in SCs; their independent associations with low VL were reflected in regression beta estimates that ranged from -0.47+/-0.23 to -0.92+/-0.32 log10 in SCs (p<0.05). Except for Cw*18, all favorable variants had diminishing or vanishing association with VL in SPs (p</=0.86).
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
###xml 158 163 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Overall, each of the three HLA class I genes had at least one allele that might contribute to effective immune control, especially during the early course of HIV-1 infection. These observations can provide a useful framework for ongoing analyses of viral mutations induced by protective immune responses.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 293 296 293 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Horton1">[1]</xref>
###xml 298 301 298 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Schreuder1">[2]</xref>
###xml 303 306 303 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Marsh1">[3]</xref>
###xml 308 311 308 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-deBakker1">[4]</xref>
###xml 392 395 392 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Hughes1">[5]</xref>
###xml 671 674 671 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Kiepiela1">[6]</xref>
###xml 676 679 676 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Honeyborne1">[7]</xref>
###xml 681 684 681 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Bansal1">[8]</xref>
###xml 823 826 823 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Bansal1">[8]</xref>
###xml 828 831 828 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Moore1">[9]</xref>
###xml 833 837 833 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Bhattacharya1">[10]</xref>
###xml 839 843 839 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Leslie1">[11]</xref>
###xml 845 849 845 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Brumme1">[12]</xref>
###xml 851 855 851 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Novitsky1">[13]</xref>
###xml 857 861 857 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Treurnicht1">[14]</xref>
###xml 1053 1057 1053 1057 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Kawashima1">[15]</xref>
###xml 1289 1293 1289 1293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Leslie1">[11]</xref>
###xml 1295 1299 1295 1299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Leslie2">[16]</xref>
###xml 12 17 <span type="species:ncbi:9606">human</span>
###xml 376 381 <span type="species:ncbi:9606">human</span>
###xml 415 450 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 452 457 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 776 783 <span type="species:ncbi:9606">patient</span>
###xml 799 804 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1072 1077 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1450 1455 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Polymorphic human leukocyte antigen (HLA) molecules facilitate immune surveillance by presenting a wide spectrum of self and foreign antigens to T-cells and by serving as ligands for killer immunoglobulin-like receptors (KIRs) on natural killer (NK) cells. The extensive HLA allelic diversity [1], [2], [3], [4] reflects positive, negative, and balancing selections by myriad human pathogens [5]. In the context of human immunodeficiency virus type 1 (HIV-1) infection, multiple HLA class I alleles have been shown to differentially influence viral pathogenesis, often as a result of their selective targeting of viral epitopes for cytotoxic T-lymphocyte (CTL) responses [6], [7], [8]. Such CTL responses frequently and often rapidly induce viral immune escape, regardless of patient populations or HIV-1 subtypes (clades) [8], [9], [10], [11], [12], [13], [14]. Viral adaptation to HLA class I-restricted, protective CTL responses can even reach fixation in a given population if the resulting viral mutations have little or no impact on viral fitness [15]. In contrast, HIV-1 variants with CTL-driven mutations that are associated with substantial fitness costs can readily revert to the wild-type once they inhabit individuals who lack the CTL-inducing HLA alleles or their equivalents [11], [16]. Understanding such intrinsic virus-HLA interplay at both the individual and population levels should help elucidate correlates of protection against HIV-1 infection, which are critical to the design of effective interventions.
###end p 9
###begin p 10
###xml 140 144 140 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Mann1">[17]</xref>
###xml 220 224 220 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Mellors1">[18]</xref>
###xml 226 230 226 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Saag1">[19]</xref>
###xml 400 404 400 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Fellay1">[20]</xref>
###xml 406 410 406 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Dalmasso1">[21]</xref>
###xml 412 416 412 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Fellay2">[22]</xref>
###xml 578 579 578 579 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 598 602 598 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Kaslow1">[23]</xref>
###xml 604 608 604 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Catano1">[24]</xref>
###xml 610 614 610 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Limou1">[25]</xref>
###xml 616 620 616 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-LeClerc1">[26]</xref>
###xml 622 626 622 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Lazaryan1">[27]</xref>
###xml 38 43 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 99 102 <span type="species:ncbi:9606">men</span>
###xml 386 391 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 532 537 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Differential impact of HLA alleles on HIV-1 viral load (VL) was first observed among seroconverted men in the Multicenter AIDS Cohort Study [17], shortly after viral load was recognized as a clinically important outcome [18], [19]. More recently, at least three independent genome-wide association studies have confirmed that HLA genes are true quantitative trait loci (QTL) related to HIV-1 viremia [20], [21], [22]. These findings are consistent with other documented associations of HLA alleles or their supertypes with rates of HIV-1 disease progression (time to AIDS or CD4+ T-cell depletion) [23], [24], [25], [26], [27], although only a few HLA alleles have been considered as universally favorable or unfavorable.
###end p 10
###begin p 11
###xml 196 200 196 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Tang1">[28]</xref>
###xml 250 254 250 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Tang2">[29]</xref>
###xml 390 394 390 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Tang3">[30]</xref>
###xml 165 170 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 180 183 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 315 320 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 574 582 <span type="species:ncbi:9606">patients</span>
###xml 584 587 <span type="species:ncbi:9606">SPs</span>
In our own work, several HLA alleles and haplotypes have been associated with low (favorable) or high (unfavorable) VL in adult Zambians predominantly infected with HIV-1 clade C (HIV-1C) viruses [28]. HLA-B*57 as a universally favorable HLA variant [29] was further associated with reduced rate (and incidence) of HIV-1 transmission from seropositive Zambians to their cohabiting partners [30]. To refine and expand these observations in our enlarged Zambian cohort, we have evaluated the potentially distinctive HLA relationships in seroconverters (SCs) and seroprevalent patients (SPs).
###end p 11
###begin title 12
Results
###end title 12
###begin title 13
###xml 27 32 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Overall Characteristics of HIV-1 Seropositive Zambians
###end title 13
###begin p 14
###xml 182 189 182 189 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
###xml 182 189 182 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0009629-t001"><bold>Table 1</bold></xref>
###xml 816 824 816 824 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1</bold>
###xml 816 824 816 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009629-g001"><bold>Figure 1</bold></xref>
###xml 866 868 866 868 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 873 874 873 874 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 943 944 941 942 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1112 1116 1108 1112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Tang3">[30]</xref>
###xml 1118 1122 1114 1118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Fideli1">[31]</xref>
###xml 1124 1128 1120 1124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Tang4">[32]</xref>
###xml 1177 1179 1173 1175 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 1221 1223 1217 1219 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 1269 1273 1265 1269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Saag1">[19]</xref>
###xml 1275 1279 1271 1275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Modjarrad1">[33]</xref>
###xml 1315 1319 1311 1315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Tang1">[28]</xref>
###xml 20 25 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 71 74 <span type="species:ncbi:9606">SPs</span>
###xml 299 302 <span type="species:ncbi:9606">SPs</span>
###xml 558 563 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 900 907 <span type="species:ncbi:9606">patient</span>
###xml 1159 1162 <span type="species:ncbi:9606">SPs</span>
For this study, 784 HIV-1 seropositive Zambian adults consisted of 563 SPs who were seropositive at enrollment and 221 SCs who became seropositive during quarterly follow-up visits (Table 1). Most of them had the first known seropositive tests between 1996 and 2004. At the time of VL measurements, SPs had a median duration of follow-up (DOF) of 546 days, while SCs had a median duration of infection (DOI) of 229 days. DOF was defined as the time interval from enrollment to first plasma sample used for VL. DOI was the interval from the estimated time of HIV-1 infection (the midpoint between last seronegative test and first seropositive test) to the first plasma taken at least 63 days after infection. Except for a few outliers, DOF and DOI relative to VL measurements were <2,000 and <600 days, respectively (Figure 1). Neither DOF nor DOI correlated with log10 VL (p>/=0.12). Between the two patient groups, statistically significant (p</=0.05) differences were seen for sex ratio, age, and the distribution of three VL categories previously shown to be highly predictive of viral transmission potential [30], [31], [32]. The minor difference between SPs and SCs in log10 VL was well within the boundary (0.30 log10) of biological and epidemiological relevance [19], [33]. For consistency with earlier work [28], sex and age group (>/=40 versus <40 years) were retained as covariates (non-genetic factors) in subsequent association models.
###end p 14
###begin title 15
###xml 16 21 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Distribution of HIV-1 viral load (VL) in the study population, with stratification by sex and serostatus at enrollment.
###end title 15
###begin p 16
###xml 68 70 68 70 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 101 102 101 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 143 145 141 143 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 168 169 166 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
There is no linear correlation between duration of follow-up and log10 VL in seroprevalent Zambians (p>/=0.12) or duration of infection and log10 VL in seroconverters (p>/=0.56). In each panel, the projected slope and its 95% confidence interval are shown in solid and dotted lines, respectively.
###end p 16
###begin title 17
###xml 41 46 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Characteristics of 563 Zambians who were HIV-1 seropositive at enrollment and 221 seroconverters who became seropositive during quarterly follow-up visits.
###end title 17
###begin p 18
###xml 328 329 328 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 370 371 368 369 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 74 77 <span type="species:ncbi:9606">SPs</span>
###xml 206 213 <span type="species:ncbi:9606">patient</span>
###xml 290 297 <span type="species:ncbi:9606">patient</span>
Dates (month/year) of seropositive tests, duration of follow-up (DOF, for SPs), and duration of infection (DOI, for SCs) are shown as median and interquartile range (in parentheses). The difference between patient groups is assessed using Mann-Whitney U test. All other comparisons between patient groups are based on Student's t-test (for quantitative measures) and chi2 test (for categorical measures). F  =  female; M  =  male; NA  =  not applicable; SD  =  standard deviation of the mean.
###end p 18
###begin title 19
HLA Class I Alleles and Their Common Haplotypes in Zambians
###end title 19
###begin p 20
###xml 95 100 95 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A</italic>
###xml 102 107 102 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B</italic>
###xml 113 118 113 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C</italic>
###xml 697 701 697 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Tang3">[30]</xref>
###xml 848 852 848 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Cao1">[34]</xref>
###xml 854 858 854 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Kiepiela2">[35]</xref>
###xml 860 864 860 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Cano1">[36]</xref>
###xml 1019 1023 1019 1023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Mann1">[17]</xref>
###xml 1025 1029 1025 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Fellay2">[22]</xref>
###xml 1031 1035 1031 1035 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Catano1">[24]</xref>
###xml 1037 1041 1037 1041 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Dorak1">[37]</xref>
###xml 12 17 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 621 626 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 678 683 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 977 982 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
For the 784 HIV-1 seropositive Zambians, molecular genotyping for the three HLA class I genes (HLA-A, HLA-B, and HLA-C) resolved most alleles to their 4-digit (high resolution) designations while leaving some at their 2-digit (allele group) specificities. HLA class I allele groups with multiple common alleles were limited to A*02, A*30, A*68, B*14, B*15, B*42, B*44, B*57, B*58, Cw*02, Cw*03, and Cw*07. The overall frequencies of HLA class I alleles and haplotypes (local and extended) in the study population were highly comparable to those seen in 429 discordant couples (858 individuals, including 204 who remained HIV-1 seronegative) analyzed previously for heterosexual HIV-1 transmission [30]. One striking observation in our population was the high frequency (17%) of B*1503-Cw*0210 (or B*15-Cw*02), a haplotype rarely reported elsewhere [34], [35], [36]. Eight HLA class I alleles (A*11, A*32, B*27, B*3502, B*3503, B*55, B*56, and Cw*05) reportedly associated with HIV-1 in populations of European ancestry [17], [22], [24], [37] were too rare to be assessed in Zambians (number of subjects ranged from one to 13).
###end p 20
###begin p 21
###xml 228 236 216 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009629.s001">Table S1</xref>
###xml 228 236 216 224 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="supplementary-material" rid="pone.0009629.s001">Table S1</xref></bold>
###xml 265 266 253 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 315 316 303 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 441 442 429 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 442 443 430 431 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 450 451 438 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 456 459 444 447 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;16</sup>
###xml 777 781 765 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Tang1">[28]</xref>
###xml 756 761 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Tests of linkage disequilibrium (LD) among HLA class I alleles focused on common allele groups seen in at least 16 individuals (approximately2% of the study population). A total of 32 common, 2-locus haplotypes were identified (Table S1). Correlation coefficients (r) in pairwise LD tests ranged from 0.17 to 0.97 (p<0.001 for all). Only two pairs of alleles, B*39 with Cw*12 plus B*42 with Cw*17, were considered as tagging for each other (r2>0.75, p<1x10-16). Accordingly, the vast majority of individual HLA class I alleles required independent testing in association analyses. Three common HLA class I combinations, A*23+B*14, A*23+Cw*07, and A*30+Cw*03, were also tested selectively because they were considered as probable haplotypes associated with HIV-1 VL in Zambians [28].
###end p 21
###begin title 22
HLA Class II Alleles and Their Common Haplotypes in Zambians
###end title 22
###begin p 23
###xml 36 44 36 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 49 57 49 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DQB1</italic>
###xml 515 516 515 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 530 531 530 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 541 549 539 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009629.s001">Table S1</xref>
###xml 541 549 539 547 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="supplementary-material" rid="pone.0009629.s001">Table S1</xref></bold>
###xml 646 647 644 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 647 648 645 646 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 657 658 655 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 663 666 661 664 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;16</sup>
###xml 937 941 935 939 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Hansen1">[38]</xref>
###xml 1129 1133 1127 1131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Tang4">[32]</xref>
###xml 1055 1060 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1110 1115 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Alleles for two HLA class II genes, HLA-DRB1 and HLA-DQB1, were fully resolved to their 4-digit designations in all but three of the 784 Zambians. Within the study population, 25 class II alleles found in at least 16 individuals qualified for formal association analyses. Strong linkage disequilibrium (LD) among alleles at these two neighboring class II loci allowed unambiguous assignment of 2-locus haplotypes in these subjects (probabilities >95% for all), leading to the identification of 19 common haplotyes (r = 0.22-0.95, p</=0.01) (Table S1). Only the neighboring alleles DRB1*0302 and DQB1*0402 were in sufficient LD to tag each other (r2 = 0.89, p<1x10-16). One common haplotype, DRB1*1301-DQB1*0501, appeared to be unique to the Zambian population. The frequency of the haplotype DRB1*1101-DQB1*0602 exceeded that of DRB1*1101-DQB1*0301 in Zambians; that excess has not been reported in other populations of African ancestry [38]. These overall allele and haplotype frequency patterns were similar to those seen in 584 Zambians (including 151 HIV-1 seronegatives) analyzed earlier for heterosexual HIV-1 transmission [32].
###end p 23
###begin title 24
Analyses Using Categorical and Quantitative VL Measures
###end title 24
###begin p 25
###xml 11 13 11 13 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 410 414 410 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Tang1">[28]</xref>
###xml 416 420 416 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Gao1">[39]</xref>
###xml 422 426 422 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-MacDonald1">[40]</xref>
###xml 428 432 428 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Lazaryan2">[41]</xref>
###xml 434 438 434 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Brumme2">[42]</xref>
###xml 542 546 542 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Tang1">[28]</xref>
###xml 548 552 548 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Kiepiela2">[35]</xref>
###xml 759 763 759 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-LeClerc1">[26]</xref>
###xml 765 769 765 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Hendel1">[43]</xref>
###xml 478 481 <span type="species:ncbi:9606">SPs</span>
###xml 633 641 <span type="species:ncbi:9606">patients</span>
###xml 744 751 <span type="species:ncbi:9606">patient</span>
We used log10 VL and two contrasting VL categories (high versus low) as alternative outcome measures in generalized linear models (GLMs) and logistic regression models to screen the effects of common HLA alleles and haplotypes, including fully resolved HLA class I alleles (e.g., A*6801, A*6802, B*3501, B*1302, B*3910, B*5801, and B*5802) implicated in earlier studies of native Africans or African-Americans [28], [39], [40], [41], [42]. The VL measure was first evaluated in SPs and SCs combined to improve statistical power (sample size) [28], [35]. The comparison between the more extreme (categorical) VL outcomes excluded 335 patients (42.7%) with intermediate VL in order to reduce the potential misclassification (overlapping) between patient groups [26], [43].
###end p 25
###begin p 26
###xml 58 63 58 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A</italic>
###xml 68 73 68 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C</italic>
###xml 164 165 164 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 175 182 173 180 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 2</bold>
###xml 175 182 173 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0009629-t002"><bold>Table 2</bold></xref>
###xml 402 406 400 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Tang1">[28]</xref>
###xml 408 412 406 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Kiepiela2">[35]</xref>
###xml 455 456 453 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 465 466 463 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 471 474 469 472 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;16</sup>
###xml 542 544 535 537 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 616 618 606 608 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 722 724 710 712 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 819 823 795 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Saag1">[19]</xref>
###xml 825 829 801 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Modjarrad1">[33]</xref>
###xml 863 864 839 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 898 899 874 875 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 908 909 884 885 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 914 917 890 893 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;16</sup>
###xml 964 965 940 941 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 129 134 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
In univariate GLMs, eight individual HLA variants and two HLA-A and HLA-C allele combinations were significantly associated with HIV-1 VL in this study population (p</=0.04) (Table 2). Five of these variants were favorable and five unfavorable, with the number of individuals carrying them ranging from 42 (5.4%) to 116 (14.8%). All variants from class I loci have shown similar associations elsewhere [28], [35]. B*57 and Cw*18, which were in strong LD (r = 0.75, p<1x10-16), were the most favorable alleles (mean beta estimates </=-0.34 log10); A*36 and DRB1*0102 were most unfavorable (mean beta close to 0.30 log10 for both). These VL differences approached and usually exceeded the quantitative threshold (+/-0.30 log10, or approximately2-fold difference) considered biologically and epidemiologically significant [19], [33]. The weak association for Cw*16 (p = 0.08) was explained by its LD (r = 0.57, p<1x10-16) with an established unfavorable allele B*45 (p = 0.05).
###end p 26
###begin title 27
###xml 40 45 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
List of 11 HLA variants associated with HIV-1 viral load (VL) based on either generalized linear models (Series 1) or logistic regression analyses (Series 2).
###end title 27
###begin p 28
###xml 155 156 155 156 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 159 160 159 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 294 301 294 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0009629-t001">Table 1</xref>
###xml 429 430 429 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 450 454 450 454 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bold</bold>
###xml 263 271 <span type="species:ncbi:9606">patients</span>
Association analyses begin with a typical, cross-sectional study design to emphasize statistical power (Series 1). In Series 2, subjects with medium VL (104-105 copies/mL) are excluded, with the assumption that they may occasionally obscure the classification of patients with low and high VL (Table 1). For consistency, sex and age are treated as covariates in each univariate analysis; statistically significant relationships (p<0.05) are shown in bold. CI  =  confidence interval; OR  =  odds ratio; SE  =  standard error.
###end p 28
###begin p 29
###xml 164 171 164 171 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 2</bold>
###xml 164 171 164 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0009629-t002"><bold>Table 2</bold></xref>
###xml 275 276 275 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 607 615 607 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009629.s002">Table S2</xref>
###xml 607 615 607 615 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="supplementary-material" rid="pone.0009629.s002">Table S2</xref></bold>
###xml 799 800 797 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1001 1009 999 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009629.s003">Table S3</xref>
###xml 1001 1009 999 1007 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="supplementary-material" rid="pone.0009629.s003">Table S3</xref></bold>
###xml 905 910 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Despite almost 43% reduction in the total sample size, the logistic regression models provided confirmatory findings for seven of 10 HLA variants detected in GLMs (Table 2). The associations of B*45, B*5802, and A*23+Cw*07 were no longer nominally statistically significant (p = 0.13, 0.08, and 0.11, respectively). Among the seven associations supported by logistic regression models, A*36 and DRB1*0102 were among the most unfavorable, while Cw*18 and B*57 were among the most favorable. These seven associations were further confirmed in alternative GLMs, where the parameter estimates improved for all (Table S2). For all 10 HLA variants associated with VL using either outcome, their rankings based on respective beta estimates and on odds ratios had a strong correlation (Spearman rho = 0.99, p<0.0001). However, the same analytic approach failed to confirm the associations of 16 HLA variants with HIV-1 disease control, as previously reported for populations of European and African ancestry (Table S3).
###end p 29
###begin title 30
###xml 23 26 <span type="species:ncbi:9606">SPs</span>
Stratified Analysis of SPs and SCs
###end title 30
###begin p 31
###xml 208 209 208 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 283 290 281 288 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 3</bold>
###xml 283 290 281 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0009629-t003"><bold>Table 3</bold></xref>
###xml 367 368 365 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 445 446 443 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 456 464 454 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009629.s001">Table S1</xref>
###xml 456 464 454 462 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="supplementary-material" rid="pone.0009629.s001">Table S1</xref></bold>
###xml 522 523 520 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 622 623 620 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 25 28 <span type="species:ncbi:9606">SPs</span>
###xml 101 106 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 195 198 <span type="species:ncbi:9606">SPs</span>
###xml 267 274 <span type="species:ncbi:9606">patient</span>
###xml 362 365 <span type="species:ncbi:9606">SPs</span>
For separate analyses of SPs and SCs, we first assessed the relationships across three categories of HIV-1 VL. Three alleles (A*36, A*74, and B*57) showed highly consistent effects on VL in both SPs and SCs (p</=0.02 in univariate Cochran-Armitage trend test in each patient group) (Table 3). Three associations (B*5802, Cw*18, and DRB1*0102) were restricted to SPs (p = 0.02, <0.0001, and <0.01, respectively). Modest LD between A*29 and B*13 (r = 0.27) (Table S1) appeared to account for the association of A*29 in SCs (p = 0.05): in the absence of B*13, the association of A*29 was no longer statistically significant (p = 0.09).
###end p 31
###begin title 32
###xml 35 40 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Distribution of 14 HLA variants in HIV-1 seroprevalent and seroconverted Zambians stratified by three levels of plasma viral load.
###end title 32
###begin p 33
###xml 92 99 92 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0009629-t004">Table 4</xref>
###xml 173 177 173 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Tang1">[28]</xref>
###xml 179 183 179 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Kiepiela2">[35]</xref>
###xml 185 189 185 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Lazaryan2">[41]</xref>
###xml 191 195 191 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Brumme2">[42]</xref>
###xml 156 159 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
HLA variants shown here have been confirmed in further analyses (generalized linear models, Table 4) or reported in earlier studies of native Africans with HIV-1C infection [28], [35], [41], [42].
###end p 33
###begin p 34
###xml 269 273 269 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Tang1">[28]</xref>
###xml 275 279 275 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Tang3">[30]</xref>
###xml 281 285 281 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Lazaryan2">[41]</xref>
###xml 324 332 324 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009629.s003">Table S3</xref>
###xml 324 332 324 332 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="supplementary-material" rid="pone.0009629.s003">Table S3</xref></bold>
###xml 334 338 334 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Kiepiela2">[35]</xref>
###xml 340 344 340 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Lazaryan2">[41]</xref>
###xml 346 350 346 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Brumme2">[42]</xref>
###xml 405 412 405 412 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 3</bold>
###xml 405 412 405 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0009629-t003"><bold>Table 3</bold></xref>
###xml 437 445 437 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009629.s003">Table S3</xref>
###xml 437 445 437 445 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="supplementary-material" rid="pone.0009629.s003">Table S3</xref></bold>
###xml 605 609 605 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Tang3">[30]</xref>
###xml 611 615 611 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Crawford1">[44]</xref>
###xml 42 47 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 61 64 <span type="species:ncbi:9606">SPs</span>
###xml 553 556 <span type="species:ncbi:9606">SPs</span>
Among HLA class I alleles associated with HIV-1 VL in either SPs or SCs or both groups, A*36 and B*5802 were unfavorable, while A*29, A*74, B*57, and Cw*18 were favorable; all of these were consistent with our earlier observations based on a smaller number of Zambians [28], [30], [41]. Alleles implicated in other studies (Table S3) [35], [41], [42] could not be confirmed in logistic regression models (Table 3) or alternative models (Table S3). Only B*57, represented primarily by B*5703 in Zambians, showed both strong internal consistency (between SPs and SCs) and unequivocal external corroboration [30], [44].
###end p 34
###begin p 35
###xml 157 159 157 159 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 190 191 190 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 201 208 199 206 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 4</bold>
###xml 201 208 199 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0009629-t004"><bold>Table 4</bold></xref>
###xml 305 306 303 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 397 398 395 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 498 499 496 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 76 81 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 160 165 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 177 180 <span type="species:ncbi:9606">SPs</span>
###xml 257 260 <span type="species:ncbi:9606">SPs</span>
By GLM, including statistical adjustments for the effects of sex and age on HIV-1 VL, only B*57 (favorable) and B*5802 (unfavorable) were associated with log10 HIV-1 VL in both SPs and SCs (p</=0.05) (Table 4). Six additional associations were seen only in SPs: unfavorable for A*36, B*45, and DRB1*0102 (p = 0.004, 0.010, and 0.002, respectively) and favorable for B*8101, Cw*18, and A*30+Cw*03 (p = 0.025, <0.0001, and 0.034, respectively). In addition, A*29 and A*74 were favorable only in SCs (p = 0.015 and <0.001, respectively).
###end p 35
###begin title 36
###xml 45 47 45 47 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 48 53 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Quantitative impact of 14 HLA variants on log10 HIV-1 viral load in two groups of Zambians.
###end title 36
###begin p 37
###xml 48 55 48 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0009629-t003">Table 3</xref>
###xml 171 175 171 175 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bold</bold>
###xml 190 191 190 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
HLA variants are the same as those presented in Table 3. The parameter estimates (mean beta and standard error, SE) are statistically adjusted for sex and age; numbers in bold have adjusted p values</=0.05.
###end p 37
###begin p 38
###xml 67 69 67 69 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 240 242 236 238 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 244 251 240 247 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 4</bold>
###xml 244 251 240 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0009629-t004"><bold>Table 4</bold></xref>
###xml 326 328 322 324 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 397 398 393 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 445 446 441 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 451 454 447 450 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;16</sup>
###xml 670 672 664 666 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 674 675 668 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 732 734 724 726 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 736 737 728 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 266 269 <span type="species:ncbi:9606">SPs</span>
###xml 418 421 <span type="species:ncbi:9606">SPs</span>
###xml 530 537 <span type="species:ncbi:9606">patient</span>
###xml 712 715 <span type="species:ncbi:9606">SPs</span>
Biologically and epidemiologically meaningful differences (0.30 log10) in VL were observed for only three most favorable HLA alleles (A*29, A*74, and B*57) in SCs, their regression beta estimates ranged from -0.42+/-0.17 to -0.62+/-0.20 log10 (Table 4). However, in SPs the respective estimates diminished by at least 0.30 log10 (a two-fold difference). Although strong LD between B*57 and Cw*18 (r = 0.74 and 0.77 in SPs and SCs, respectively, p<1x10-16 for both) would have predicted similar impact of these two alleles in both patient groups, the impact of B*57 appeared stronger in SCs. B*13 (all B*1302 in this cohort) was clearly favorable in SCs (-0.78+/-0.33 log10, p = 0.02), but its effect vanished in SPs (0.03+/-0.16 log10, p = 0.86).
###end p 38
###begin p 39
###xml 169 176 169 176 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 4</bold>
###xml 169 176 169 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0009629-t004"><bold>Table 4</bold></xref>
###xml 294 302 294 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009629.s003">Table S3</xref>
###xml 294 302 294 302 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="supplementary-material" rid="pone.0009629.s003">Table S3</xref></bold>
###xml 305 309 305 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Tang1">[28]</xref>
###xml 311 315 311 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Kiepiela2">[35]</xref>
###xml 317 321 317 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Lazaryan2">[41]</xref>
###xml 323 327 323 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Brumme2">[42]</xref>
###xml 74 77 <span type="species:ncbi:9606">SPs</span>
###xml 146 149 <span type="species:ncbi:9606">SPs</span>
The effect sizes of the unfavorable A*36 and B*5802 varied little between SPs and SCs. For B*45 and DRB1*0102, the unfavorable effect observed in SPs was absent in SCs (Table 4). Again, the same analytic approach did not confirm or imply the involvement of other HLA alleles of major interest (Table S3) [[28], [35], [41], [42].
###end p 39
###begin title 40
###xml 46 48 46 48 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
Multivariable Analyses of HLA Variants and log10 VL
###end title 40
###begin p 41
###xml 131 133 131 133 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 149 150 149 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 167 174 167 174 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 5</bold>
###xml 167 174 167 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0009629-t005"><bold>Table 5</bold></xref>
###xml 281 282 281 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 298 305 298 305 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 5</bold>
###xml 298 305 298 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0009629-t005"><bold>Table 5</bold></xref>
###xml 463 465 451 453 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 520 522 506 508 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 587 588 573 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 37 40 <span type="species:ncbi:9606">SPs</span>
In a reduced multivariable model for SPs, A*36 and DRB1*0102 continued to show unfavorable association with VL (+0.25 and +0.38 log10, respectively, p<0.01 for both) (Table 5), while at least five HLA alleles and one HLA combination were retained as additional cofactors (adjusted p<0.05 for all) (Table 5). Based on their respective effect sizes (adjusted beta estimates), B*57, B*8101, and A*30+Cw*03 had similarly favorable impact on VL (approximately-0.30 log10), and A*74 showed more modest impact (-0.20+/-0.08 log10). Cw*18 could replace B*57 and B*8101 as an independent factor (p<0.0001), but the association of B*57 and B*8101 was no longer statistically significant when the three variants were forced into the same model (results not shown).
###end p 41
###begin title 42
###xml 32 34 32 34 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 54 59 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 84 87 <span type="species:ncbi:9606">SPs</span>
Multifactorial influences on log10 viral load (VL) in HIV-1 seroprevalent Zambians (SPs) and seroconverters (SCs).
###end title 42
###begin p 43
###xml 164 168 164 168 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bold</bold>
###xml 212 215 <span type="species:ncbi:9606">SPs</span>
The parameter estimates (mean beta and standard error, SE) are adjusted for all factors retained in each model. Because of strong LD (see text), B*57 and Cw*18 (in bold) are entered into separate models for both SPs and SCs.
###end p 43
###begin p 44
###xml 158 160 158 160 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 194 195 182 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 514 517 <span type="species:ncbi:9606">SPs</span>
In SCs, favorable HLA class I alleles and one 2-allele combination dominated the independent effects, with mean beta estimates ranging from -0.47 to -0.92 log10 (approximately3.0- to 8.3-fold) (p<0.05). These effects were ranked as B*13>B*57>A*74>(A*30+Cw*03) or B*13>A*74>Cw*18>(A*30+Cw*03) when B*57 was replaced Cw*18 in the reduced multivariable model. The adjusted effect sizes attributed to all five favorable HLA variants in aggregate exceeded the effect sizes for age and sex. In contrast to the model for SPs, a model for SCs that included both B*57 and Cw*18 indicated a non-significant association with Cw*18 (data not shown).
###end p 44
###begin p 45
###xml 102 109 102 109 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 5</bold>
###xml 102 109 102 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0009629-t005"><bold>Table 5</bold></xref>
###xml 170 175 170 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A</italic>
###xml 180 185 180 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B</italic>
###xml 255 259 255 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Sidney1">[45]</xref>
In further assessment of favorable and unfavorable HLA variants retained in the multivariable models (Table 5), it was evident that they did not segregate by a) specific HLA-A and HLA-B supertypes, including those that have been added or refined recently [45], b) HLA serological groups (properties as alloantigens), or c) relative frequency that might introduce allelic bias in homozygosity and heterozygosity within the study population.
###end p 45
###begin title 46
Discussion
###end title 46
###begin p 47
###xml 56 58 56 58 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 219 223 219 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Tang1">[28]</xref>
###xml 1130 1134 1130 1134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Tang1">[28]</xref>
###xml 1136 1140 1136 1140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Kiepiela2">[35]</xref>
###xml 1142 1146 1142 1146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Lazaryan2">[41]</xref>
###xml 1148 1152 1148 1152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Brumme2">[42]</xref>
###xml 1361 1369 1361 1369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009629.s002">Table S2</xref>
###xml 1361 1369 1361 1369 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="supplementary-material" rid="pone.0009629.s002">Table S2</xref></bold>
###xml 1462 1466 1462 1466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-LeClerc1">[26]</xref>
###xml 1468 1472 1468 1472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Hendel1">[43]</xref>
###xml 444 447 <span type="species:ncbi:9606">SPs</span>
###xml 462 465 <span type="species:ncbi:9606">SPs</span>
###xml 767 770 <span type="species:ncbi:9606">SPs</span>
###xml 991 994 <span type="species:ncbi:9606">SPs</span>
###xml 1095 1100 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1196 1203 <span type="species:ncbi:9606">patient</span>
###xml 1431 1439 <span type="species:ncbi:9606">patients</span>
Our expanded analyses of VL as a quantitative trait (log10 copy number) or as a categorical outcome measure in adult Zambians confirmed most of the favorable and unfavorable HLA associations that we previously reported [28]; this study also yielded three new, internally consistent findings. First, the associations of most of the favorable HLA class I alleles were more readily detected in seroconverters (SCs) than in seroprevalent subjects (SPs), even though SPs outnumbered SCs by 2-fold. HLA-A*74, B*57 (or Cw*18), and A*30+Cw*03 were clearly favorable; B*13 also appeared favorable in the few SCs with this allele. For each of these variants, its biologically and epidemiologically meaningful impact on VL either substantially diminished or totally vanished in SPs. Second, individual alleles and haplotypes at HLA class II loci were not prominently associated with altered viremia at the population level. Only one class II allele (DRB1*0102) was associated with high VL, and only in SPs. No other HLA class II allele or haplotype, including any previously reported to be associated with HIV-1 transmission or acquisition [[28], [35], [41], [42], showed appreciable impact on VL in either patient group. Third, an alternative study design that included only about 60% of the population with the two extreme categories of VL yielded very similar results (Table S2). In resource-limited settings that require concentration on patients with extreme outcomes [26], [43], considerable savings in cost may be achieved with relatively little loss of power, especially for exploratory studies of genetic determinants.
###end p 47
###begin p 48
###xml 261 265 261 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Fideli1">[31]</xref>
###xml 267 271 267 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Quinn1">[46]</xref>
###xml 327 331 327 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Mellors1">[18]</xref>
###xml 333 337 333 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Lyles1">[47]</xref>
###xml 339 343 339 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Mellors2">[48]</xref>
###xml 485 489 485 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Tang1">[28]</xref>
###xml 551 556 551 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B</italic>
###xml 594 598 594 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Kiepiela2">[35]</xref>
###xml 727 728 727 728 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 773 777 773 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Brumme2">[42]</xref>
###xml 965 970 965 970 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A</italic>
###xml 1121 1126 1121 1126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B</italic>
###xml 1131 1136 1131 1136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C</italic>
###xml 1311 1316 1311 1316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B</italic>
###xml 1417 1422 1417 1422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A</italic>
###xml 36 41 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 242 247 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1329 1334 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Plasma VL during untreated, chronic HIV-1 infection reflects an equilibrium between viral replication and immunologically mediated viral clearance. Population-based studies have clearly established the predictive value of VL for heterosexual HIV-1 transmission [31], [46] as well as time to AIDS, especially in Caucasian males [18], [47], [48]. Although our initial work indicated that variants from all three HLA class I genes were associated with VL in chronically infected Zambians [28], similar work based on a South African cohort has shown that HLA-B allele played the most dominant role [35]. In the same South African cohort, several favorable HLA alleles (B*42, B*57, B*5801, and B*8101) were further predictive of CD4+ T-cell slope over a 2-year follow-up period [42]. Our analyses here did not support the favorable association of B*42, although A*29 as a marginally favorable allele in Zambians (seroconverters only) showed weak LD with B*42. Two other HLA-A alleles (A*36 as unfavorable and A*74 as favorable) had even stronger associations, none of which could be explained by effects of their accompanying HLA-B and HLA-C alleles. Both alleles have been confirmed in recent analyses of African-Americans (unpublished results, available from RAK and JT). Thus, although the influences of multiple HLA-B variants on HIV-1 pathogenesis and evolution have been more readily detected and confirmed, several HLA-A alleles can exert comparable effects.
###end p 48
###begin p 49
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B</italic>
###xml 10 15 10 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C</italic>
###xml 116 120 116 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Dawkins1">[49]</xref>
###xml 122 126 122 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Yunis1">[50]</xref>
###xml 128 132 128 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Miretti1">[51]</xref>
###xml 134 138 134 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Smith1">[52]</xref>
###xml 140 144 140 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Romero1">[53]</xref>
###xml 183 188 183 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C</italic>
###xml 330 335 330 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B</italic>
###xml 421 425 421 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Tang3">[30]</xref>
###xml 705 710 705 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C</italic>
###xml 840 845 840 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C</italic>
###xml 850 855 850 855 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A</italic>
###xml 1001 1006 1001 1006 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C</italic>
###xml 1063 1067 1063 1067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Fellay1">[20]</xref>
###xml 1069 1073 1069 1073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Thomas1">[54]</xref>
###xml 1211 1215 1211 1215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Idaghdour1">[55]</xref>
###xml 722 727 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 910 915 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HLA-B and HLA-C genes are located in a genomic segment (the beta block) rarely disrupted by recombination hot spots [49], [50], [51], [52], [53]. As a result, the associations of two HLA-C alleles (Cw*16 as unfavorable and Cw*18 as favorable) with VL in Zambians could be partially or completely explained by their strong LD with HLA-B alleles: B*45 for Cw*16 and B*57 plus B*8101 for Cw*18. However, as we noted earlier [30], experimental evidence does suggest that Cw*1801 is able to present viral epitopes for cytotoxic T-lymphocyte (CTL) responses, which might account for its relatively durable impact on VL. Identification of one favorable A-C combination (A*30+Cw*03) further supported the role of HLA-C alleles in HIV-1 infection, because none of these alleles individually had a clear association with VL. Assuming that alleles at HLA-C and HLA-A can act in concert to confer genetic advantage during HIV-1 infection (or disadvantage in other settings), differences in peptide-binding and in HLA-C allelic expression can offer two plausible explanations [20], [54]. Of note, environmental factors can further complicate the genotype-phenotype relationships by influencing gene expression in leukocytes [55].
###end p 49
###begin p 50
###xml 97 98 97 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 110 111 110 111 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 256 257 256 257 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 413 414 413 414 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 538 542 538 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Douek1">[56]</xref>
###xml 669 670 669 670 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 721 725 721 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Ramduth1">[57]</xref>
###xml 812 816 812 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Cantin1">[58]</xref>
###xml 818 822 818 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Cantin2">[59]</xref>
###xml 824 828 824 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-StumptnerCuvelette1">[60]</xref>
###xml 830 834 830 834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Schindler1">[61]</xref>
###xml 944 948 944 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Kaslow1">[23]</xref>
###xml 950 954 950 954 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Tang4">[32]</xref>
###xml 956 960 956 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Malhotra1">[62]</xref>
###xml 1253 1254 1253 1254 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 294 299 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 451 456 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 637 642 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 682 690 <span type="species:ncbi:9606">patients</span>
###xml 704 707 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 755 760 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1127 1130 <span type="species:ncbi:9606">SPs</span>
HLA class II molecules specialize in presenting exogenous antigens for immune surveillance by CD4+ T-helper (TH) cells. Their peptide-binding grooves can be loaded with protein degradation products (13-25 amino-acid residues) generated in the lysosome. CD4+ T-cells that effectively respond to HIV-1 antigens can facilitate immune control through cytokines and T-cell-dependent antibody responses, but activated TH cells, especially those specific to HIV-1 antigens, are lost rapidly because they are preferentially targeted by the virus [56]. Striking a balance between the two functions can be difficult. Recent work has identified 33 HIV-1 epitopes recognized by CD4+ T-cells in patients with chronic HIV-1C infection [57]. Direct interactions between HIV-1 and HLA class II molecules have also been reported [58], [59], [60], [61]. Among individual HLA class II alleles, DRB1*1301 has been seen as a favorable allele in various populations [23], [32], [62]. Our analyses here failed to confirm any of the previously reported HLA class II alleles or haplotypes. Instead, DRB1*0102 was associated with higher VL, but only in SPs. The relationship counters to the hypothesized early involvement of class II molecules, before the precipitous loss of CD4+ T-cells. The largely inconclusive findings for HLA class II alleles and haplotypes might reflect their promiscuity in antigen presentation.
###end p 50
###begin p 51
###xml 174 178 174 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Tang1">[28]</xref>
###xml 180 184 180 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Tang3">[30]</xref>
###xml 186 190 186 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Tang4">[32]</xref>
###xml 432 436 432 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Tang2">[29]</xref>
###xml 553 557 553 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Brumme1">[12]</xref>
###xml 559 563 559 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Honeyborne2">[63]</xref>
###xml 565 569 565 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Geldmacher1">[64]</xref>
###xml 652 656 652 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Crawford1">[44]</xref>
###xml 658 662 658 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Goepfert1">[65]</xref>
###xml 753 756 753 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Honeyborne1">[7]</xref>
###xml 758 762 758 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Brumme2">[42]</xref>
###xml 764 768 764 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Harrer1">[66]</xref>
###xml 770 774 770 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Brumme3">[67]</xref>
###xml 776 780 776 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Emu1">[68]</xref>
###xml 782 786 782 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Prado1">[69]</xref>
###xml 1091 1095 1091 1095 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Leslie1">[11]</xref>
###xml 1097 1101 1097 1101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Brumme1">[12]</xref>
###xml 1103 1107 1103 1107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Yu1">[70]</xref>
###xml 1109 1113 1109 1113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Karlsson1">[71]</xref>
###xml 1115 1119 1115 1119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Crawford2">[72]</xref>
###xml 1331 1335 1331 1335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Tang3">[30]</xref>
###xml 22 25 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 128 133 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 538 543 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 904 907 <span type="species:ncbi:9606">SPs</span>
###xml 1233 1238 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1471 1476 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Within the context of HIV-1C infection, the Zambian cohort has produced some of the first evidence that HLA factors can mediate HIV-1 VL as well as heterosexual transmission [28], [30], [32]. Identification of favorable HLA factors in this cohort is particularly encouraging, as relatively few HLA alleles have unequivocal (consensus) effects in various investigations, especially in the era of highly active antiretroviral therapy [29]. For the few favorable HLA class I alleles confirmed in the Zambian, several have known or predicted HIV-1 epitopes [12], [63], [64]. For example, epitope-specific functional correlation is well documented for B*57 [44], [65]. B*13 (all B*1302 in Zambians) is another class I allele repeatedly observed as favorable [7], [42], [66], [67], [68], [69]. The impact of the favorable HLA class I alleles and haplotypes on VL was consistently more prominent in SCs than in SPs, suggesting that immune control mediated by favorable alleles like B*57 and B*13 diminish with time, most likely due to viral immune escape and accumulation of compensatory mutations [11], [12], [70], [71], [72]. Further association of favorable HLA alleles (B*57 and Cw*18) with reduced rates and incidences of heterosexual HIV-1 transmission in the Zambian cohort was also most apparent during the early follow-up period [30]. Continuing efforts to monitor the evolution of viral epitopes targeted by favorable HLA variants should provide critical guidance for HIV-1 vaccine design and clinical trials.
###end p 51
###begin p 52
###xml 23 25 23 25 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 93 95 93 95 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 186 190 174 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Saag1">[19]</xref>
###xml 192 196 180 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Modjarrad1">[33]</xref>
###xml 379 386 367 374 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 5</bold>
###xml 379 386 367 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0009629-t005"><bold>Table 5</bold></xref>
###xml 754 758 742 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Brenchley1">[73]</xref>
###xml 826 830 814 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Pellegrin1">[74]</xref>
###xml 832 836 820 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Kulkarni1">[75]</xref>
###xml 1005 1008 993 996 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gag</italic>
###xml 1018 1022 1006 1010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Novitsky1">[13]</xref>
###xml 1024 1028 1012 1016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Crawford1">[44]</xref>
###xml 647 652 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 738 743 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 999 1004 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1256 1261 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
When expressed as a log10 value (a continuous variable), VL differences greater than 0.30 log10 (approximately2-fold) are often considered biologically and epidemiologically significant [19], [33]. By our analyses, at least four favorable HLA class I alleles and one favorable combination independently conferred biologically and epidemiologically important impact on VL in SCs (Table 5). By contrast, the absence of advantageous class II variants highlights the importance of CTL and likely natural killer (NK) cell activities mediated by the three HLA class I genes. In particular, one or both of these pathways must be effective in controlling HIV-1 infection, since VL set-point is typically reached within the first nine weeks after HIV-1 infection [73], before the debut of high-affinity neutralizing antibody responses [74], [75]. Again, collection of longitudinal VL and viral sequencing data from SCs will help determine the timing and scope of viral immune escape, as already reported for HIV-1 gag variants [13], [44]. In addition, ongoing elucidation of KIR genotypes should set the stage for thorough, systematic evaluation of HLA-KIR interaction, which is the second and potentially critical pathway by which HLA class I alleles may regulate HIV-1 infection.
###end p 52
###begin title 53
Materials and Methods
###end title 53
###begin title 54
Ethics Statement
###end title 54
###begin p 55
###xml 29 34 <span type="species:ncbi:9606">human</span>
###xml 108 113 <span type="species:ncbi:9606">Human</span>
###xml 141 149 <span type="species:ncbi:9606">patients</span>
This study complied with the human experimentation guidelines of the United States Department of Health and Human Services, and all enrolled patients provided written informed consent. The work presented here was further approved by the Institutional Review Boards at University of Alabama at Birmingham, under Protocols X051108005 and X071119002.
###end p 55
###begin title 56
###xml 18 23 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Study Population, HIV-1 Viral Load (VL), and HLA Genotyping
###end title 56
###begin p 57
###xml 267 271 267 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Fideli1">[31]</xref>
###xml 273 277 273 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Goepfert1">[65]</xref>
###xml 279 283 279 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Trask1">[76]</xref>
###xml 285 289 285 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Allen1">[77]</xref>
###xml 291 295 291 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Kempf1">[78]</xref>
###xml 957 961 957 961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Tang3">[30]</xref>
###xml 963 967 963 967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Li1">[79]</xref>
###xml 1164 1168 1164 1168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Robinson1">[80]</xref>
###xml 1170 1174 1170 1174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Holdsworth1">[81]</xref>
###xml 19 24 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 96 101 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 320 325 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Beginning in 1995, HIV-1 seropositive Zambians were recruited and followed by the Rwanda/Zambia HIV-1 Research Group in Lusaka, Zambia. Procedures for quarterly medical examination, voluntary counseling and testing, and viral sequencing have been described elsewhere [31], [65], [76], [77], [78]. Measurements of plasma HIV-1 VL (RNA copies) were made in most cases with the Roche Amplicor 1.0 assay (Roche Diagnostics Systems Inc., Branchburg, NJ), which had a lower limit of detection (LLD) of 400 RNA copies per ml of plasma. HLA genotyping relied on a combination of PCR-based methods, including PCR with sequence-specific primers (SSP) (Dynal/Invitrogen, Brown Deer, WI), automated sequence-specific oligonucleotide (SSO) probe hybridization (Innogenetics, Alpharetta, GA), and sequencing-based typing (SBT) (Abbott Molecular, Inc., Des Plaines, IL) using capillary electrophoresis and the ABI 3130xl DNA Analyzer (Applied Biosystems, Foster City, CA) [30], [79]. HLA alleles were resolved to the first four digits, which correspond to distinct protein products designated by the World Health Organization Nomenclature Committee for Factors of the HLA System [80], [81].
###end p 57
###begin title 58
Computational Assignment of Local and Extended HLA Haplotypes
###end title 58
###begin p 59
###xml 145 150 145 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B</italic>
###xml 155 160 155 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C</italic>
###xml 252 256 252 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Tang3">[30]</xref>
###xml 297 305 297 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 310 318 310 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DQB1</italic>
###xml 367 371 367 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Tang4">[32]</xref>
###xml 575 576 575 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
Using the expectation-maximization (EM) algorithm in SAS Genetics (SAS Institute, Cary, NC), common HLA class I B-C haplotypes were assigned for HLA-B and HLA-C alleles because of their known, strong linkage disequilibrium (LD) in the study population [30]. DRB1-DQB1 haplotypes were assigned for HLA-DRB1 and HLA-DQB1 alleles in the same way and for the same reason [32]. Assignments of these 2-locus (local) haplotypes helped to distinguish allelic from haplotypic effects. Assignments of extended haplotypes were assessed by relative LD (D') and correlation coefficients (r). In a given individual, simultaneous assignments of two haplotypes with a statistical probability >/=70% by the EM algorithm were considered reliable. Individuals with unreliable haplotype assignments (probabilities <70%) were excluded from formal testing of haplotypic associations.
###end p 59
###begin title 60
Descriptive Statistics
###end title 60
###begin p 61
###xml 139 146 139 146 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
###xml 139 146 139 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0009629-t001"><bold>Table 1</bold></xref>
###xml 283 284 283 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 306 308 306 308 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 329 330 327 328 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 31 36 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 61 64 <span type="species:ncbi:9606">SPs</span>
###xml 176 183 <span type="species:ncbi:9606">patient</span>
The overall characteristics of HIV-1 seroprevalent Zambians (SPs) and seroconverters (SCs) with complete HLA genotyping were summarized in Table 1. Differences between the two patient groups were assessed using Mann-Whitney U test (fro duration of infection or follow-up), Student's t-test (for age and log10 viral load), and chi2 test (for sex ratio, age group, and three categories of viral load).
###end p 61
###begin title 62
###xml 40 45 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Analyses of HLA Variants in Relation to HIV-1 VL
###end title 62
###begin p 63
###xml 107 111 107 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Tang1">[28]</xref>
###xml 113 117 113 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Tang3">[30]</xref>
###xml 119 123 119 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Fideli1">[31]</xref>
###xml 125 129 125 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Tang5">[82]</xref>
###xml 131 135 131 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Song1">[83]</xref>
###xml 1195 1196 1195 1196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1207 1208 1207 1208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1455 1457 1453 1455 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 1477 1481 1475 1479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Saag1">[19]</xref>
###xml 1483 1487 1481 1485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009629-Modjarrad1">[33]</xref>
###xml 239 242 <span type="species:ncbi:9606">SPs</span>
###xml 281 284 <span type="species:ncbi:9606">SPs</span>
###xml 513 516 <span type="species:ncbi:9606">SPs</span>
###xml 597 605 <span type="species:ncbi:9606">patients</span>
###xml 610 613 <span type="species:ncbi:9606">SPs</span>
The statistical approach to association analysis followed the strategies established in other related work [28], [30], [31], [82], [83], except that a) enlarged sample size (improved statistical power) facilitated separate analyses of 563 SPs versus 221 SCs, b) 56 individuals (32 SPs and 24 SCs) representing couples with unlinked viruses were retained in analyses because HLA genotyping had already been completed before non-identity of the virus in suspected recipients (seroconverters) was established; c) 19 SPs from cohabiting couples with short (<9 mth) follow-up were also included; d) 18 patients (15 SPs and 3 SCs) with VL less than the lower limit of detection (400 copies/mL) were excluded; e) several univariate models were presented in order to facilitate meta-analysis; f) software packages in SAS was updated to version 9.2 (SAS Institute), and g) results sorted in SAS were used to produce graphs using GraphPad Prism version 5.0 (). Summary statistics in association analyses included: 1) proportional odds ratio (pOR) and 95% confidence intervals (CIs); 2) regression beta estimates, expressed as means and standard errors (SE), and 3) univariate and multivariable (adjusted) p values. A p value</=0.050 was considered statistically significant because most HLA alleles and haplotypes highlighted in this work have been implicated in earlier studies. The overall emphasis was on biologically and epidemiologically significant (>0.30 log10) differences in VL [19], [33].
###end p 63
###begin title 64
Supporting Information
###end title 64
###begin p 65
HLA class I and class II alleles and haplotypes found in at least 16 out of 784 adult Zambians.
###end p 65
###begin p 66
(0.04 MB DOC)
###end p 66
###begin p 67
Click here for additional data file.
###end p 67
###begin p 68
###xml 32 34 32 34 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 35 40 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HLA variants associated with log10 HIV-1 viral load (VL) based on alternative generalized linear models.
###end p 68
###begin p 69
(0.05 MB DOC)
###end p 69
###begin p 70
Click here for additional data file.
###end p 70
###begin p 71
Dismissal of 16 candidate HLA variants reported in earlier studies and common in Zambians.
###end p 71
###begin p 72
(0.07 MB DOC)
###end p 72
###begin p 73
Click here for additional data file.
###end p 73
###begin p 74
###xml 25 37 <span type="species:ncbi:9606">participants</span>
###xml 58 63 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
We thank staff and study participants in the Zambia-Emory HIV-1 Research Project for their valuable contributions to various aspects of this study. We are also grateful to Ulgen Fideli and Amanda Tichacek for data management, to Dongning He, Yirong Ni, and Wenshuo Shao for technical assistance, and to Yun Joo Yun for structuring SAS programming templates.
###end p 74
###begin title 75
References
###end title 75
###begin article-title 76
###xml 25 30 <span type="species:ncbi:9606">human</span>
Gene map of the extended human MHC.
###end article-title 76
###begin article-title 77
HLA dictionary 2004: summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens.
###end article-title 77
###begin article-title 78
Nomenclature for factors of the HLA system, 2004.
###end article-title 78
###begin article-title 79
###xml 92 97 <span type="species:ncbi:9606">human</span>
A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC.
###end article-title 79
###begin article-title 80
Natural selection and the diversification of vertebrate immune effectors.
###end article-title 80
###begin article-title 81
###xml 35 38 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
CD8+ T-cell responses to different HIV proteins have discordant associations with viral load.
###end article-title 81
###begin article-title 82
###xml 11 46 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Control of human immunodeficiency virus type 1 is associated with HLA-B*13 and targeting of multiple gag-specific CD8+ T-cell epitopes.
###end article-title 82
###begin article-title 83
###xml 33 38 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Immunological control of chronic HIV-1 infection: HLA-mediated immune function and viral evolution in adolescents.
###end article-title 83
###begin article-title 84
###xml 12 17 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level.
###end article-title 84
###begin article-title 85
###xml 37 40 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Founder effects in the assessment of HIV polymorphisms and HLA allele associations.
###end article-title 85
###begin article-title 86
###xml 0 3 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
HIV evolution: CTL escape mutation and reversion after transmission.
###end article-title 86
###begin article-title 87
###xml 110 115 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Evidence of differential HLA class I-mediated viral evolution in functional and accessory/regulatory genes of HIV-1.
###end article-title 87
###begin article-title 88
###xml 22 29 22 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 59 64 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Timing constraints of in vivo Gag mutations during primary HIV-1 subtype C infection.
###end article-title 88
###begin article-title 89
###xml 20 25 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Adaptive changes in HIV-1 subtype C proteins during early infection are driven by changes in HLA-associated immune pressure.
###end article-title 89
###begin article-title 90
###xml 14 19 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 23 28 <span type="species:ncbi:9606">human</span>
Adaptation of HIV-1 to human leukocyte antigen class I.
###end article-title 90
###begin article-title 91
###xml 89 92 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Transmission and accumulation of CTL escape variants drive negative associations between HIV polymorphisms and HLA.
###end article-title 91
###begin article-title 92
###xml 118 153 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Major histocompatibility complex genotype is associated with disease progression and virus load levels in a cohort of human immunodeficiency virus type 1-infected Caucasians and African Americans.
###end article-title 92
###begin article-title 93
###xml 13 18 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Prognosis in HIV-1 infection predicted by the quantity of virus in plasma.
###end article-title 93
###begin article-title 94
###xml 0 3 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
HIV viral load markers in clinical practice.
###end article-title 94
###begin article-title 95
###xml 75 80 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A whole-genome association study of major determinants for host control of HIV-1.
###end article-title 95
###begin article-title 96
###xml 37 40 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 58 61 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 76 81 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Distinct genetic loci control plasma HIV-RNA and cellular HIV-DNA levels in HIV-1 infection: the ANRS Genome Wide Association 01 study.
###end article-title 96
###begin article-title 97
###xml 44 49 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 53 59 <span type="species:ncbi:9606">humans</span>
Common genetic variation and the control of HIV-1 in humans.
###end article-title 97
###begin article-title 98
###xml 29 34 <span type="species:ncbi:9606">human</span>
###xml 91 96 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection.
###end article-title 98
###begin article-title 99
###xml 50 55 50 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZNRD1</italic>
###xml 57 61 57 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCP5</italic>
###xml 66 71 66 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C</italic>
###xml 114 121 114 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-A10</italic>
###xml 125 133 125 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-B*57</italic>
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 disease-influencing effects associated with ZNRD1, HCP5 and HLA-C alleles are attributable mainly to either HLA-A10 or HLA-B*57 alleles.
###end article-title 99
###begin article-title 100
Genomewide association study of an AIDS-nonprogression cohort emphasizes the role played by HLA genes (ANRS Genomewide Association Study 02).
###end article-title 100
###begin article-title 101
Genomewide association study of a rapid progression cohort identifies new susceptibility alleles for AIDS (ANRS Genomewide Association Study 03).
###end article-title 101
###begin article-title 102
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 47 52 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Human leukocyte antigen class I supertypes and HIV-1 control in African Americans.
###end article-title 102
###begin article-title 103
###xml 109 144 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Favorable and unfavorable HLA class I alleles and haplotypes in Zambians predominantly infected with clade C human immunodeficiency virus type 1.
###end article-title 103
###begin article-title 104
###xml 31 34 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The impact of host genetics on HIV infection and disease progression in the era of highly active antiretroviral therapy.
###end article-title 104
###begin article-title 105
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 70 73 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Human leukocyte antigen class I genotypes in relation to heterosexual HIV type 1 transmission within discordant couples.
###end article-title 105
###begin article-title 106
###xml 71 106 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 108 113 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 (HIV-1) in Africa.
###end article-title 106
###begin article-title 107
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
###xml 14 18 14 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DQB1</italic>
###xml 118 153 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
HLA-DRB1 and -DQB1 alleles and haplotypes in Zambian couples and their associations with heterosexual transmission of human immunodeficiency virus type 1.
###end article-title 107
###begin article-title 108
###xml 37 40 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Impact of small reductions in plasma HIV RNA levels on the risk of heterosexual transmission and disease progression.
###end article-title 108
###begin article-title 109
Analysis of the frequencies of HLA-A, B, and C alleles and haplotypes in the five major ethnic groups of the United States reveals high levels of diversity in these loci and contrasting distribution patterns in these populations.
###end article-title 109
###begin article-title 110
###xml 71 74 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA.
###end article-title 110
###begin article-title 111
Common and well-documented HLA alleles: Report of the ad-hoc committee of the American Society for Histocompatiblity and Immunogenetics.
###end article-title 111
###begin article-title 112
###xml 21 26 <span type="species:ncbi:9606">Human</span>
Immunobiology of the Human MHC.
###end article-title 112
###begin article-title 113
Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS.
###end article-title 113
###begin article-title 114
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 64 69 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Human leucocyte antigen supertypes and immune susceptibility to HIV-1, implications for vaccine design.
###end article-title 114
###begin article-title 115
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 42 77 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Human leukocyte antigen B58 supertype and human immunodeficiency virus type 1 infection in native Africans.
###end article-title 115
###begin article-title 116
###xml 84 92 <span type="species:ncbi:9606">patients</span>
###xml 106 111 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Impact of select immunologic and virologic biomarkers on CD4 cell count decrease in patients with chronic HIV-1 subtype C infection: results from Sinikithemba Cohort, Durban, South Africa.
###end article-title 116
###begin article-title 117
New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS.
###end article-title 117
###begin article-title 118
###xml 24 29 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703-positive individuals and their transmission recipients.
###end article-title 118
###begin article-title 119
HLA class I supertypes: a revised and updated classification.
###end article-title 119
###begin article-title 120
###xml 44 79 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group.
###end article-title 120
###begin article-title 121
###xml 19 54 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 137 140 <span type="species:ncbi:9606">men</span>
Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study.
###end article-title 121
###begin article-title 122
###xml 20 25 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 119 124 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Prognostic value of HIV-1 RNA, CD4 cell count, and CD4 Cell count slope for progression to AIDS and death in untreated HIV-1 infection.
###end article-title 122
###begin article-title 123
Genomics of the major histocompatibility complex: haplotypes, duplication, retroviruses and disease.
###end article-title 123
###begin article-title 124
###xml 51 56 <span type="species:ncbi:9606">human</span>
Inheritable variable sizes of DNA stretches in the human MHC: conserved extended haplotypes and their fragments or blocks.
###end article-title 124
###begin article-title 125
###xml 52 57 <span type="species:ncbi:9606">human</span>
A high-resolution linkage-disequilibrium map of the human major histocompatibility complex and first generation of tag single-nucleotide polymorphisms.
###end article-title 125
###begin article-title 126
Toward understanding MHC disease associations: partial resequencing of 46 distinct HLA haplotypes.
###end article-title 126
###begin article-title 127
###xml 22 27 <span type="species:ncbi:9606">human</span>
Genetic fixity in the human major histocompatibility complex and block size diversity in the class I region including HLA-E.
###end article-title 127
###begin article-title 128
###xml 91 96 91 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-C</italic>
###xml 45 48 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C.
###end article-title 128
###begin article-title 129
###xml 25 30 <span type="species:ncbi:9606">human</span>
Geographical genomics of human leukocyte gene expression variation in southern Morocco.
###end article-title 129
###begin article-title 130
###xml 0 3 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 27 30 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
HIV preferentially infects HIV-specific CD4+ T cells.
###end article-title 130
###begin article-title 131
###xml 15 20 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 71 76 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Immunodominant HIV-1 CD4+ T cell epitopes in chronic untreated clade C HIV-1 infection.
###end article-title 131
###begin article-title 132
###xml 91 126 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 183 188 <span type="species:ncbi:9606">human</span>
The acquisition of host-derived major histocompatibility complex class II glycoproteins by human immunodeficiency virus type 1 accelerates the process of virus entry and infection in human T-lymphoid cells.
###end article-title 132
###begin article-title 133
###xml 40 75 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
The presence of host-derived HLA-DR1 on human immunodeficiency virus type 1 increases viral infectivity.
###end article-title 133
###begin article-title 134
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Nef impairs MHC class II antigen presentation and surface expression.
###end article-title 134
###begin article-title 135
###xml 161 166 <span type="species:ncbi:9606">human</span>
###xml 171 200 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
Down-modulation of mature major histocompatibility complex class II and up-regulation of invariant chain cell surface expression are well-conserved functions of human and simian immunodeficiency virus nef alleles.
###end article-title 135
###begin article-title 136
###xml 35 40 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Role for HLA class II molecules in HIV-1 suppression and cellular immunity following antiretroviral treatment.
###end article-title 136
###begin article-title 137
Motif inference reveals optimal CTL epitopes presented by HLA class I alleles highly prevalent in southern Africa.
###end article-title 137
###begin article-title 138
###xml 136 171 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 185 193 <span type="species:ncbi:9606">patients</span>
CD8 T-cell recognition of multiple epitopes within specific Gag regions is associated with maintenance of a low steady-state viremia in human immunodeficiency virus type 1-seropositive patients.
###end article-title 138
###begin article-title 139
###xml 16 21 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients.
###end article-title 139
###begin article-title 140
###xml 111 116 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 126 134 <span type="species:ncbi:9606">patients</span>
A conserved HLA B13-restricted cytotoxic T lymphocyte epitope in Nef is a dominant epitope in HLA B13-positive HIV-1-infected patients.
###end article-title 140
###begin article-title 141
###xml 72 77 <span type="species:ncbi:9606">human</span>
###xml 103 108 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 175 180 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Marked epitope- and allele-specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early HIV-1 infection.
###end article-title 141
###begin article-title 142
###xml 73 101 <span type="species:ncbi:12721">human immunodeficiency virus</span>
HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control.
###end article-title 142
###begin article-title 143
###xml 27 55 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Functional consequences of human immunodeficiency virus escape from an HLA-B*13-restricted CD8+ T-cell epitope in p1 Gag protein.
###end article-title 143
###begin article-title 144
###xml 80 115 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Mutually exclusive T-cell receptor induction and differential susceptibility to human immunodeficiency virus type 1 mutational escape associated with a two-amino-acid difference between HLA class I subtypes.
###end article-title 144
###begin article-title 145
###xml 48 53 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Sequential broadening of CTL responses in early HIV-1 infection is associated with viral escape.
###end article-title 145
###begin article-title 146
###xml 160 195 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Compensatory mutation partially restores fitness and delays reversion of escape mutation within the immunodominant HLA-B*5703-restricted Gag epitope in chronic human immunodeficiency virus type 1 infection.
###end article-title 146
###begin article-title 147
###xml 0 3 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
HIV disease: fallout from a mucosal catastrophe?
###end article-title 147
###begin article-title 148
###xml 56 64 <span type="species:ncbi:9606">patients</span>
###xml 88 93 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Kinetics of appearance of neutralizing antibodies in 12 patients with primary or recent HIV-1 infection and relationship with plasma and cellular viral loads.
###end article-title 148
###begin article-title 149
###xml 62 67 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Neutralizing antibody responses in recent seroconverters with HIV-1 subtype C infections in India.
###end article-title 149
###begin article-title 150
###xml 26 61 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Molecular epidemiology of human immunodeficiency virus type 1 transmission in a heterosexual cohort of discordant couples in Zambia.
###end article-title 150
###begin article-title 151
###xml 19 22 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 48 51 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Sexual behavior of HIV discordant couples after HIV counseling and testing.
###end article-title 151
###begin article-title 152
###xml 28 31 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Enrollment and retention of HIV discordant couples in Lusaka, Zambia.
###end article-title 152
###begin article-title 153
###xml 46 54 46 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HLA-DRB1</italic>
Clear and independent associations of several HLA-DRB1 alleles with differential antibody responses to hepatitis B vaccination in youth.
###end article-title 153
###begin article-title 154
The IMGT/HLA database.
###end article-title 154
###begin article-title 155
The HLA dictionary 2008: a summary of HLA-A, -B, -C, -DRB1/3/4/5, and -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens.
###end article-title 155
###begin article-title 156
###xml 71 76 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Host genetic profiles predict virological and immunological control of HIV-1 infection in adolescents.
###end article-title 156
###begin article-title 157
###xml 96 101 <span type="species:ncbi:9606">human</span>
Genetic epidemiology of glioblastoma multiforme: Confirmatory and new findings from analyses of human leukocyte antigen alleles and motifs.
###end article-title 157
###begin p 158
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 158
###begin p 159
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by National Institute of Allergy and Infectious Diseases (NIAID), through grants AI040951 (to S.A.), AI071906 (to R.A.K.), and AI064060 (to E.H). J.T. is the recipient of an Independent Scientist Award (AI76123) from NIAID. The funders had no role in study design, data collection, data analyses, decision to publish, or preparation of this manuscript.
###end p 159

